Natixis Advisors LLC Acquires 4,069 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Key Points

• Natixis Advisors LLC increased its stake in HealthEquity, Inc. by 2.2%, owning approximately 188,059 shares valued at $16.6 million, highlighting continued institutional confidence in the company.
• Several institutional investors, including FMR LLC and Brown Advisory Inc., have also raised their positions in HealthEquity during the fourth quarter, with 99.55% of the stock now owned by institutional investors.
• Despite recent **insider selling**, with executives offloading nearly 292,000 shares in the last quarter, HealthEquity reported strong earnings, beating analysts' estimates with $0.97 EPS compared to the forecasted $0.81.

Natixis Advisors LLC increased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 2.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 188,059 shares of the company's stock after purchasing an additional 4,069 shares during the quarter. Natixis Advisors LLC owned 0.22% of HealthEquity worth $16,619,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Bayforest Capital Ltd raised its stake in shares of HealthEquity by 65.7% in the first quarter. Bayforest Capital Ltd now owns 5,025 shares of the company's stock worth $444,000 after buying an additional 1,992 shares during the period. Vestcor Inc raised its stake in shares of HealthEquity by 296.2% in the first quarter. Vestcor Inc now owns 19,655 shares of the company's stock worth $1,737,000 after buying an additional 14,694 shares during the period. Premier Fund Managers Ltd raised its stake in shares of HealthEquity by 3,601.6% in the first quarter. Premier Fund Managers Ltd now owns 409,992 shares of the company's stock worth $35,610,000 after buying an additional 398,916 shares during the period. Federated Hermes Inc. raised its stake in shares of HealthEquity by 18.8% in the first quarter. Federated Hermes Inc. now owns 9,756 shares of the company's stock worth $862,000 after buying an additional 1,547 shares during the period. Finally, Carrera Capital Advisors grew its position in shares of HealthEquity by 6.3% during the first quarter. Carrera Capital Advisors now owns 24,029 shares of the company's stock worth $2,123,000 after purchasing an additional 1,418 shares in the last quarter. 99.55% of the stock is owned by institutional investors.

Insider Activity at HealthEquity

In related news, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction that occurred on Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares of the company's stock, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Elimelech Rosner sold 58,000 shares of the company's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.56, for a total value of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares of the company's stock, valued at $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 291,744 shares of company stock valued at $32,705,007 over the last three months. 1.50% of the stock is owned by insiders.

HealthEquity Price Performance

HealthEquity stock traded down $0.14 during mid-day trading on Tuesday, hitting $91.01. 1,315,290 shares of the company were exchanged, compared to its average volume of 887,472. The company has a market capitalization of $7.87 billion, a P/E ratio of 66.43, a PEG ratio of 1.41 and a beta of 0.54. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06. HealthEquity, Inc. has a 12-month low of $67.00 and a 12-month high of $116.65. The business's 50 day simple moving average is $100.81 and its two-hundred day simple moving average is $98.09.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The firm had revenue of $330.80 million during the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter in the previous year, the business earned $0.80 earnings per share. Analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. Wall Street Zen upgraded HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. Barrington Research boosted their price objective on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a report on Thursday, June 5th. Deutsche Bank Aktiengesellschaft boosted their price objective on HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. Royal Bank Of Canada boosted their price objective on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Finally, KeyCorp dropped their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $118.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.